|
China Everbright Limited Announces 2023 Interim Results, Realises Turnaround of Loss to Profit
HONG KONG, Aug 25, 2023 - (ACN Newswire) - On 25 August 2023, China Everbright Limited ("CEL" or the "Company", stock code: 165.HK) announced its interim results for the six months ended 30 June 2023 ("the reporting period").
Financial Highlights of 2023 Interim Results -- The overall operating revenue was HK$1.54 billion, representing a steady increase in overall operating results -- Profit attributable to shareholders of the Company was HK$313 million, realising a turnaround from loss to profit. -- Fund raising continued and total AUM reached approximately HK$154.8 billion. -- Diversified exits achieved a cash return of approximately HK$3.244 billion -- Maintained strong liquidity with cash and cash equivalents of approximately HK$10.406 billion and unutilised bank facilities available for use of approximately HK$10.222 billion. -- Maintained dividend with interim dividend: HK$0.15 per share
In the first half of 2023, confronted with the challenges of a volatile and intricate global financial environment, CEL steadily adjusted its business strategy, accelerating the Company's transformation and development. With a rebound in the capital market, the performance of the fund management business improved significantly and investment returns markedly increased, driving the steady increase in the Company's overall operating results. During the reporting period, CEL achieved an overall operating revenue of HK$1.54 billion, and the profit attributable to shareholders of the Company was HK$313 million, representing a significant elevation from the same period last year and marking a turnaround from a loss to a profit.
During the reporting period, CEL continued its fundraising efforts and raised new funds of HK$1.302 billion. CEL's total assets under management (AUM) reached HK$154.8 billion with 78 funds. The Company's diversified exit channels resulted in good returns, with a total capital return of HK$3.244 billion from the exit business.
To share the fruits of the Company's development with shareholders and investors, the Board of Directors declared interim dividend of HK$0.15 per share for 2023. (2022 interim dividend: HK$0.15 per share).
Business Highlights of 2023 Interim Results
1. Fund Management Business In the first half of 2023, CEL reinforced its management in fundraising, investment, management and exit business, strengthened its internal control, and continued to improve its risk-prevention ability to achieve a gradual transition into high-quality development and maintain its leading market position in the field of fund management in China.
Fundraising proceeds steadily. Despite fundraising difficulties in industries, CEL Yixing FoFs was newly established and raised new funds of HK$1.302 billion. The new fund will mainly focus on industries including energy conservation, environmental protection, integrated circuit, and new energy, with a view to serving the economic development of the Yangtze River Delta region.
Capture investment opportunities prudently. During the reporting period, CEL maintained a prudent attitude and invested in key projects including Grit Science and Reforgene Medicine.
Gain remarkable income from exit business. There was a capital return of HK$3.244 billion in total from the exit business in key projects including ASR Microelectronics, Googut, Three's Company Media, Ambrx, and Rici Healthcare, realising an income of approximately HK$1.232 billion against costs, contributing good investment returns and cash inflow for CEL.
2. Key Investee Companies CALC grows steadily. Since the end of 2022, the number of CALC's aircraft increased by 13 to 189, and now consists of 162 owned aircraft and 27 managed aircraft. CALC's owned and managed aircraft are leased to 42 airlines in 20 countries and regions.
Everbright Senior Healthcare continues improving competitiveness. It constantly optimised the three-level elderly service model featuring institutional, community-based, and home-based elderly services, improved the ability of "Medical + Senior Healthcare", "Insurance + Senior Healthcare" and "Service + Senior Healthcare". It has 190 institutional and community service centers covering over 50 cities across the country, forming a deployment covering the Beijing-Tianjin-Hebei region, Yangtze River Delta, and Chengdu-Chongqing Economic Circle, with more than 32,000 beds under management.
Terminus achieves highly industry recognition. Terminus actively promoted market expansion, focused on high-growth business opportunities, and comprehensively enhanced its overall strength. During the reporting period, in collaboration with The Hong Kong University of Science and Technology (Guangzhou), the "Digital World" Joint Research Center was established to advance major scientific research projects and applications in the field of Artificial Intelligence of Things (AIoT). Terminus received multiple honours and has been widely recognised in the industry, including being awarded the "2023 AIGC Application Scenario Innovation Top 50" by EqualOcean.
3. Rich Resource Reserves Retain sufficient liquidity reserve. At the end of June 2023, CEL had cash and cash equivalents of approximately HK$10.406 billion and unutilised bank facilities available for use of approximately HK$10.222 billion, representing a sufficient liquidity condition.
Increase the coverage depth of technology innovation resources. The incubator at China Everbright Hong Kong Innovation Centre hit and beat the target earlier than expected by introducing six new enterprises and attracting the first foreign enterprise.
Serve key regional development. CEL carried out in-depth overall planning for the Beijing-Tianjin-Hebei region, the Yangtze River Delta and the Guangdong-Hong Kong-Macao Greater Bay Area, increased investments in real economy, supported and served major national strategies, and served the domestic and international "dual circulation" actively.
4. Continuous Improvement of Environmental, Social and Governance Fulfil social responsibilities. CEL assisted in launching the "Millions of Youngsters in China and Thousands of Doctors in the Divine Land" programme. The Company also participated in the HKSAR's "Strive and Rise Programme" for youth development and aims to expand the horizon of Hong Kong's youth through the promotion of arts and culture.
Improve ESG management policy on an ongoing basis. CEL issued separate and self-contained ESG reports to disclose information in relation to responsible investment and TCFD. CEL closely followed changes in the industry and was rewarded with a continuous increase of MSCI ESG rating with the latest score of 5.2.
Improve the Company's management policy on an ongoing basis. CEL continued improving the institutional construction of funds establishment and management to promote an operation in compliance with laws and regulations on an ongoing basis. CEL addressed external risk-related issues and strengthened risk prevention and review, and organised training sessions on new regulations for the private equity fund industry to raise awareness about operating in compliance with laws and regulations.
Looking ahead to the second half of 2023, with continued coordinated efforts in macroeconomic policies and the sustained recovery of the economy, there will be significant resilience and potential for development. CEL will insist on the general principle of ensuring stability and promoting high-quality development as a cornerstone, while giving priority to performance in order to continuously improve the core competitiveness of private equity investments.
In terms of fundraising, CEL will develop fund products with a focus on advantageous industries, laying a foundation for the growth of its asset management portfolio and revenue enhancement. In terms of investments, the Company will focus on specialised industries with competitive advantages, particularly technological innovation companies, and strictly select specialised and new enterprises, consumer goods and environmental companies. CEL will continue to strengthen post-investment management and build solid lines of defence against risks to ensure investment projects are "clear, manageable and rewarding". In terms of investment exit, the Company will continue to exit expeditely with better strategies.The Company will continue to increase efforts to exit from existing investment projests through M&A, transfer and IPO, so as to recover funds.
Mr. Zhang Mingao, Executive Director and President of China Everbright Limited, said: "In the first half of 2023, there was steady recovery in the Chinese economy and a significant upturn. CEL upheld a firm development confidence, steadily adjusted business strategies and accelerated transformation and development. The overall operational performance stabilized and rebounded, successfully achieving a turnaround of losses into profits. Going forward, CEL will focus on developing the private equity investment management market and maintaining its strategic focus on long-term investments while continuing to deploy our specialized industries with unique strengths. CEL will seize the fundamentals of Chinese economic recovery, firmly grasp the period with opportunities brought by the industrial policy adjustments and proactively push forward business transformation to optimize the full-chain equity investment system of 'fundraising, investment, management and exit', and achieve high-quality development of the cross-border asset management market to bring long-term sustainable growth returns to shareholders and investors."
For enquiries, please contact: Citigate Dewe Rogerson Samantha Wang Email: samantha.wang@citigatedewerogerson.com Tel: +852 3103 0125
April Tang Email: april.tang@citigatedewerogerson.com Tel: +852 3103 0105
Source: China Everbright Ltd Sectors: Daily Finance, Funds & Equities
Copyright ©2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
Latest Release
 The University of Tokyo and NEC conclude a Strategic Collaboration Agreement to promote a prosperous society where people and AI succeed together Mar 17, 2026 12:34 JST
|  Hitachi Energy Japan Recognized as a 2026 Health & Productivity Management Outstanding Organization (Large Enterprise Category) Mar 16, 2026 16:20 JST
|  Fujitsu Japan and Teikyo University Hospital launch joint proof of concept to build mechanism for data analysis and referred-patient management Mar 16, 2026 12:55 JST
|  FWD Group delivers record full year 2025 results with profitable growth, improved capital and cash flow generation Mar 16, 2026 10:25 JST
|  Mitsubishi Shipbuilding Completes Handover of WAKASHIO MARU Training Ship for National Institute of Technology, Toyama College Mar 13, 2026 16:01 JST
|  Mitsubishi Heavy Industries to Introduce 10MW-Class Centrifugal Chiller for Next-Generation AI Data Centers in North America Mar 13, 2026 14:10 JST
|  Spritzer Sparkling's 'Serikan Raya, Sparkling-kan Suasana' Festive Fusion Message Promotes Togetherness and Tradition with a Light, Modern Twist Mar 13, 2026 12:45 JST
|  Hitachi to deliver the world's first 550 kV gas-insulated switchgear in which the entire equipment is SF(6)-free to Chubu Electric Power Grid Mar 12, 2026 19:40 JST
|  Honda Announces Losses Associated with Reassessment of Automobile Electrification Strategy; Revision to Forecast for Consolidated Financial Results; and Future Direction
Mar 12, 2026 19:02 JST
|  Japantastics Introduces the World of Kodaimoji, Bringing Ancient Characters into Modern Spaces Mar 12, 2026 19:00 JST
|  Eisai Launches Awareness Campaign on Importance of Sleep Through "Pokemon Sleep" Collaboration Mar 12, 2026 17:21 JST
|  NEC Develops Physical AI That Anticipates Human Movement and Psychological States Mar 12, 2026 16:41 JST
|  NEC and The University of Tokyo calculate carbon accumulation rates in Malaysian national park with a 9.4% margin of error Mar 12, 2026 12:02 JST
|  Everest Medicines Announces Commercial Launch and First Prescription for VELSIPITY(R) in Mainland China, Addressing Unmet Need in Moderately to Severely Active Ulcerative Colitis Mar 11, 2026 20:15 JST
|  Eisai to Present the Latest Data on Long-Term, Real-World Treatment with Lecanemab at the AD/PD(TM) 2026 Annual Meeting Mar 11, 2026 12:07 JST
|  Fujitsu launches Japan's first defense tech open innovation program Mar 10, 2026 11:45 JST
|  Fujitsu and DT-Axis collaborate to advance digital health Mar 09, 2026 13:32 JST
| Hong Kong Completes First Green Methanol Bunkering, Driving Green Transformation of Its International Shipping Hub Mar 08, 2026 16:05 JST
|  International Women's Day: Why Menopause May Be a Missed Cardiovascular Risk Window Mar 06, 2026 20:00 JST
|  TANAKA Develops World's First High-Performance Palladium Hydrogen Permeable Membrane Exhibiting High Hydrogen Purification Performance at Temperatures around 100 degrees C Mar 05, 2026 22:00 JST
|
More Latest Release >>
|